NDC 60505-3121 – Fenofibrate
Fenofibrate 130 mg/1 · Capsule · Oral
Product NDC60505-3121
Product details
- Brand name
- Fenofibrate
- Generic name
- Fenofibrate
- Labeler
- Apotex Corp.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA202252
- Marketed since
- July 26, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Peroxisome Proliferator Receptor alpha Agonist
Active ingredients
- Fenofibrate 130 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 60505-3121-1 | 100 CAPSULE in 1 BOTTLE (60505-3121-1) | Jul 26, 2013 |
| 60505-3121-3 | 30 CAPSULE in 1 BOTTLE (60505-3121-3) | Jul 26, 2013 |
| 60505-3121-5 | 500 CAPSULE in 1 BOTTLE (60505-3121-5) | Jul 26, 2013 |
| 60505-3121-9 | 90 CAPSULE in 1 BOTTLE (60505-3121-9) | Jul 26, 2013 |
Other Fenofibrate products
- 50090-7994 Fenofibrate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6120 Fenofibrate 134 mg/1 · Capsule · A-S Medication Solutions
- 27241-118 Fenofibrate 67 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-120 Fenofibrate 200 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-119 Fenofibrate 134 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 62332-086 Fenofibrate 200 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-085 Fenofibrate 134 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-084 Fenofibrate 67 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-084 Fenofibrate 67 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-085 Fenofibrate 134 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-086 Fenofibrate 200 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 60687-713 Fenofibrate 200 mg/1 · Capsule · American Health Packaging